Moderate Babesiosis

Drug	Drug Name	Drug Description
DB01117	Atovaquone	An antimicrobial indicated for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP) and for the prevention and treatment of Plasmodium falciparum malaria.

Drug	Drug Name	Target	Type
DB01117	Atovaquone	Dihydroorotate dehydrogenase (quinone), mitochondrial	target
DB01117	Atovaquone	Dihydroorotate dehydrogenase (quinone), mitochondrial	target
DB01117	Atovaquone	Cytochrome b	target
DB01117	Atovaquone	Cytochrome P450 2C9	enzyme
DB01117	Atovaquone	Cytochrome P450 3A4	enzyme
DB01117	Atovaquone	P-glycoprotein 1	transporter

Drug	Drug Name	Phase	Status	Count